Natural products as the calcium channel blockers for the treatment of arrhythmia: Advance and prospect.


Journal

Fitoterapia
ISSN: 1873-6971
Titre abrégé: Fitoterapia
Pays: Netherlands
ID NLM: 16930290R

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 25 04 2023
revised: 27 06 2023
accepted: 29 06 2023
medline: 21 8 2023
pubmed: 8 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Arrhythmia is one of the commonly heart diseases with observed abnormal heart-beat rhythm that caused by the obstacles of cardiac activity and conduction. The arrhythmic pathogenesis is complex and capricious and related with other cardiovascular diseases that may lead to heart failure and sudden death. In particular, calcium overload is recognized as the main reason causing arrhythmia through inducing apoptosis in cardiomyocytes. Moreover, calcium channel blockers have been widely used as the routine drugs for the treatment of arrhythmia, but the different arrhythmic complications and adverse effects limit their further applications and demand new drug discovery. Natural products have always been the rich minerals for the development of new drugs that could be employed as the versatile player for the discovery of safe and effective anti-arrhythmia drugs with new mechanisms. In this review, we summarized natural products with the activity against calcium signaling and the relevant mechanism of actions. We are expected to provide an inspiration for the pharmaceutical chemists to develop more potent calcium channel blockers for the treatment of arrhythmia.

Identifiants

pubmed: 37419421
pii: S0367-326X(23)00175-2
doi: 10.1016/j.fitote.2023.105600
pii:
doi:

Substances chimiques

Calcium Channel Blockers 0
Biological Products 0
Anti-Arrhythmia Agents 0
Calcium SY7Q814VUP

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105600

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lu Xiao (L)

China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China.

Xing-Juan Chen (XJ)

China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China.

Ji-Kang Feng (JK)

Linyi Zhengzhi Hospital, Linyi 276004, China.

Wei-Na Li (WN)

China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China.

Shuo Yuan (S)

Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450018, China. Electronic address: zzuyuanshuo@163.com.

Ying Hu (Y)

China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China; Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: huyingdr@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH